These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-000417-18 A phase III, randomised, mulicentre dose escalation, efficacy and safety study examining the effects of treatment with peginterferon alfa-2a in patients with Child's A or B cirrhosis in chronic hepati... 2010-12-01 due-trials
Other 2004-000502-40 A thematic analysis of semi-structured interviews using a phenomenological approach into palliative care patients experiences of change in "fatigue" following treatment with methylphenidate – an explo... not-yet-due
Completed, but no date, and reported results Terminated 2005-005164-83 A PHASE 2 STUDY OF CARBOPLATIN IN COMBINATION WITH GEMCITABINE AS A DOSE DENSE SCHEDULE IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER THAT ARE RESISTANT TO ANTHRACYCLINES & TAXANES. bad-data
Completed, but no date Terminated 2005-005849-19 Finite duration treatment in pre-cirrhotic chronic hepatitis B virus (HBV) infection: Phase IV study of Lamivudine priming of Pegasys treatment in HBeAg positive patients bad-data
Reported results 2006-003121-82 A prospective randomised open label trial of oxaliplatin / irinotecan plus fluorouracil versus oxaliplatin / irinotecan plus fluorouracil and cetuximab pre and post operatively in patients with resect... 2018-05-22 due-trials
Not reported Terminated 2006-003424-12 A randomised phase II clinical trial using targeted radiotherapy delivered by an Yttrium-90 radiolabelled Anti-CD66 monoclonal antibody with high dose melphalan compared to melphalan alone, prior to a... 2013-10-31 due-trials
Other 2006-004419-24 The Use of Sulfasalazine as an Anti-fibrotic in Acute Alcoholic Hepatitis not-yet-due
Not reported Terminated 2007-000222-51 Short CHemo RadioImmunotherapy in Follicular Trial of 90Y Ibritumomab tiuxetan (ZevalinTM) as therapy for first and second relapse in Follicular Lymphoma 2015-01-06 due-trials
Other 2007-001716-23 A Double-Blind Randomised Placebo-Controlled Trial of Vitamin D Supplements for Pregnant Women with Low Levels of Vitamin D in Early Pregnancy not-yet-due
Not reported Terminated 2007-002788-28 Evaluation of Corticosteroid therapy in Childhood Severe Sepsis (Steroids in Paediatric Sepsis, StePS) - a randomised pilot study 2012-06-30 due-trials
Other 2007-005547-17 Refeeding risks in patients requiring nutrition support. A twin centre double-blind randomised controlled trial of parenteral nutrition support. not-yet-due
Other 2008-001769-27 Microbiological assessment of prophylactic ciprofloxacin therapy for children with cystic fibrosis during viral respiratory viral infection to prevent Pseudomonas aeruginosa colonisation – a randomise... not-yet-due
Reported results 2008-003766-26 The effects of purified n-3 fatty acids on serum biomarkers and cardiovascular risk markers in a randomized placebo controlled trial in patients with non alcoholic fatty liver disease 2018-11-29 due-trials
Other 2008-007043-14 A Pilot Study of Clofarabine Pre-Conditioning Prior to Full or Reduced Intensity Allogeneic Transplantation in the Treatment of High Risk Acute Myeloid Leukaemia and Myelodysplasia not-yet-due
Reported results 2009-011587-11 INVESTIGATING THE CLINICAL USE OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PREVENAR)IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA 2015-08-14 due-trials
Ongoing 2009-012432-32 RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE AND HIGH-DOSE CYTARABINE WITH OR WITHOUT THIOTEPA, AND WITH OR WITHOUT RITUXIMAB, FOLLOWED BY BRAIN IRRADIATION vs. HIGH-D... not-yet-due
Other 2009-013791-49 Safety and Efficacy of parenteral KGF in moderate asthma subjects not-yet-due
Reported results 2009-013897-42 STOPAH: STeroids Or Pentoxifylline for Alcoholic Hepatitis 2014-02-28 due-trials
Reported results 2009-015679-28 PRIMARY PREVENTION OF ATOPY AND ASTHMA WITH ALLERGEN SUBLINGUAL IMMUNOTHERAPY 2014-03-06 due-trials
Other 2009-015876-86 An investigation into the mechanisms of action of a combined long acting beta agonist/inhaled corticosteroid (Seretide 500 accuhaler) on the bacterial colonisation, immunology and inflammation of pati... not-yet-due
Reported results Terminated 2009-017340-14 WT1 Immunity via DNA fusion Gene Vaccination in Haematological Malignancies by intramuscular injection followed by intramuscular electroporation. 2014-03-25 due-trials
Reported results 2010-021863-34 A phase II trial of the addition of ipilumimab to carboplatin and etoposide chemotherapy for the first line treatment of extensive small cell lung cancer 2015-09-30 due-trials
Other 2010-022422-32 A randomised evaluation of molecular guided therapy for diffuse large B-cell lymphoma with Bortezomib not-yet-due
Reported results 2010-022461-10 A pilot study investigating the antiplatelet effect of generic clopidogrel versus Plavix™ – is there any difference in platelet reactivity in healthy subjects? 2012-03-05 due-trials
Reported results Terminated 2010-023529-39 Reducing antibiotic tolerance using low dose nitric oxide in cystic fibrosis – a phase 2 pilot study 2012-09-26 due-trials
Other 2010-023668-42 Pulmonary surfactant (S) biology in ventilated children on a paediatric intensive care unit with acute (A) hypoxic respiratory (R) failure- a pilot (P) study (S): (SARPS) not-yet-due
Other 2011-000811-23 Treatment of neonatal chronic lung disease (nCLD). The Surfactant, Nutrition and Microorganism Interactions study in infants at risk of developing chronic lung disease - 2 (TSuNaMI-II) not-yet-due
Reported results Terminated 2011-003052-40 An exploratory study to investigate the optimal scheduling of chemotherapy in patients with operable colorectal liver metastases 2014-06-17 due-trials
Reported results 2012-001509-25 COAST - Cisplatin Ototoxicity attenuated by Aspirin Trial A randomised, Phase II, double-blind, placebo-controlled, two arm Trial to establish whether Aspirin can reduce hearing loss/ototoxicity for p... 2016-06-30 due-trials
Other 2012-003698-25 Proof of concept clinical trial examining the effect of clopidogrel on allergen challenge in asthma not-yet-due
Reported results Terminated 2013-002031-26 Safety of Nasal Influenza Immunisation in Egg Allergic Children - The SNIFFLE study 2014-01-31 due-trials
Other 2013-002854-66 Southampton Pregnancy Intervention for the Next Generation - a randomised controlled trial of vitamin D and nurse support in improving the diet and body composition of young women and their children. not-yet-due
Exempt 2013-004642-41 Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care not-yet-due
Not reported 2013-004657-24 A randomised, double-blind, placebo controlled, feasibility study exploring the role of Chinese herbal medicine in the treatment of women with recurrent urinary tract infections. 2018-03-05 due-trials
Not reported 2014-001537-92 Safety of Nasal Influenza Immunisation in Egg Allergic Children - The SNIFFLE 2 study 2015-02-28 due-trials
Exempt 2014-002061-30 Therapeutic HPV vaccine trial +/- anti-CD40 in HPV-driven squamous cell carcinoma. not-yet-due
Exempt 2015-002231-18 A Phase I/IIa Study of Targeted Radiotherapy alone for Stem Cell Transplant Conditioning in Systemic AL Amyloidosis not-yet-due
Exempt 2015-003213-18 A Phase Ib/II combination trial of acalabrutinib with rituximab, cyclophosphamide, doxorubicin,vincristine and prednisolone (R-CHOP) for patients with diffuse large B-cell lymphoma (DLBCL) not-yet-due
Exempt, with results 2015-004062-29 SGI-110 to potentiate platinum response: A phase Ib/randomised IIa open label clinical trial combining SGI-110 with cisplatin and gemcitabine chemotherapy 2020-06-01 not-yet-due
Reported results 2016-000113-70 Clinical efficacy and mechanistic evaluation of Eplerenone for Central serous chorio-retinopathy – the VICI randomised trial. 2019-06-03 due-trials
Exempt 2016-002221-11 A Phase I study of 131-1 mIBG followed by Nivolumab and Dinutuximab beta in children with relapsed/refractory neuroblastoma not-yet-due
Other 2016-002654-21 A PHASE II STUDY OF ATEZOLIZUMAB WITH RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA WHO ARE NOT CANDIDATES FOR HIGH-DOSE THERAPY. not-yet-due
Exempt, with results Terminated 2016-003291-47 A phase Ib/IIa clinical trial to combine the CSF1 receptor inhibitor pexidartinib with the androgen receptor antagonist enzalutamide in metastatic castration resistant prostate cancer 2019-01-11 not-yet-due
Other 2017-000302-37 A phase IIa study of Rituximab and Varlilumab in relapsed or refractory B-cell malignancies not-yet-due
Other 2018-000242-19 Change in nutritional state and postoperative outcome following preoperative introduction of nutritional supplements and pancreatic enzymes in patients undergoing Whipple’s procedure for pancreatic ca... not-yet-due
Not reported 2018-001546-33 IBD Biosimilar to Biosimilar Infliximab Switching Study 2020-02-20 due-trials
Other 2018-004967-30 IBD Reference and Biosimilar adalimumab CroSS over Study not-yet-due
Other 2019-001310-42 A RANDOMIZED PHASE II TRIAL ASSESSING TRIMODALITY THERAPY WITH OR WITHOUT ADJUVANT DURVALUMAB (MEDI4736) TO TREAT PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER not-yet-due
Other 2020-001736-95 ACCORD 2: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID 19 in Hospitalised Patients not-yet-due
Other 2020-001886-35 A clinical trial of nebulized surfactant for the Treatment of moderate to severe COVID-19 in adults not-yet-due
Other 2020-004463-25 SWitching InflixiMab to SUbcut from Intravenous Therapy not-yet-due